This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Martlet Capital
Visit WebsitePortfolio company
United Kingdom
Sector: Life Sciences & Therapeutics
Martlet Capital is an early-stage investor, providing patient capital to deep technology and life science startups.
Martlet Capital has invested in more than 65 start-ups, since its launch in 2011. The company provides patient capital for early-stage B2B deep technology and life science start-ups, with a primary focus on companies based in Cambridge.
In 2021, Martlet successfully raised additional capital to scale its investment activity.
Subsidiaries
Portfolio
- ProAxsis
- Glycotest
- Cetromed
- PDS Biotechnology
- Vortex Biosciences
- Wanda Health
- Q-Bot
- Sofant Technologies
- PointGrab
- SageTech Medical
- Dname-iT
- Oncocidia
- Ventive
- DeepTech Recycling
- G-Tech Medical
- FOx Biosystems
- EpiBone
- Cytovale
- Longevity Biotech
- QuantalX Neuroscience
- Insight Photonics
- Nanotech Industrial Solutions
- Martlet Capital